An Economic Evaluation of rt-PA Locking Solution in Dialysis Catheters

In a recent randomized trial, weekly recombinant tissue plasminogen activator (rt-PA), 1 mg per lumen, once per week, and twice-weekly heparin as a locking solution (rt-PA/heparin) resulted in lower risks of hemodialysis catheter malfunction and catheter-related bacteremia compared with thrice-weekl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Soc Nephrol
Egile Nagusiak: Manns, Braden J., Scott-Douglas, Nairne, Tonelli, Marcello, Ravani, Pietro, LeBlanc, Martine, Dorval, Marc, Holden, Rachel, Moist, Louise, Lok, Charmaine, Zimmerman, Deborah, Au, Flora, Hemmelgarn, Brenda R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2014
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4243340/
https://ncbi.nlm.nih.gov/pubmed/25012176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013050463
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak